4 days ago
Piper Sandler Sticks to Their Hold Rating for Oscar Health (OSCR)
Piper Sandler analyst Jessica Tassan maintained a Hold rating on Oscar Health yesterday and set a price target of $13.00. The company's shares closed yesterday at $14.93.
Elevate Your Investing Strategy:
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Tassan is an analyst with an average return of -6.8% and a 36.08% success rate. Tassan covers the Healthcare sector, focusing on stocks such as Oscar Health, Omnicell, and UnitedHealth.
In addition to Piper Sandler, Oscar Health also received a Hold from TR | OpenAI – 4o's Soren Coverra in a report issued on August 8. However, yesterday, Wells Fargo maintained a Sell rating on Oscar Health (NYSE: OSCR).
Based on Oscar Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.05 billion and a net profit of $275.27 million. In comparison, last year the company earned a revenue of $2.14 billion and had a net profit of $177.37 million
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OSCR in relation to earlier this year.
